Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares
November 26, 2019 16:05 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of...
Forward Pharma to Participate in the Fall Investor Summit in New York
September 05, 2019 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in...
Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock Exchange
June 26, 2019 16:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, June 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced its intention to transfer its public listing of American Depositary Shares from...
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018
April 04, 2019 16:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 04, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...
Forward Pharma to Participate in the DKBIO2019 Life Science Investor Conference
March 27, 2019 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, March 27, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference
October 24, 2018 10:42 ET
|
Forward Pharma A/S
The U.S. Court of Appeals for the Federal Circuit has affirmed the decision of the Patent Trial and Appeal Board in the U.S. patent interference proceedingThe appeal of the European EP2801355 patent...
Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Conference
September 28, 2018 07:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018
September 19, 2018 16:20 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We”, “Forward” or the “Company” and together with its subsidiaries, the “Group”), today reported...
Forward Pharma to Participate in the LSX Nordic Congress
August 23, 2018 08:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
May 07, 2018 16:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, May 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (“We” or “Forward” or the “Company”), today announced the filing of a notice of appeal of the decision of the...